Equities

Sapporo Clinical Laboratory Inc

9776:TYO

Sapporo Clinical Laboratory Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)973.00
  • Today's Change1.00 / 0.10%
  • Shares traded300.00
  • 1 Year change-2.70%
  • Beta0.4077
Data delayed at least 20 minutes, as of Nov 15 2024 06:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments3,9763,6642,991
Total Receivables, Net2,9192,9242,995
Total Inventory579515491
Prepaid expenses------
Other current assets, total222208753
Total current assets7,6977,3117,230
Property, plant & equipment, net8,1918,4498,128
Goodwill, net------
Intangibles, net969060
Long term investments210150142
Note receivable - long term0.44--0.01
Other long term assets340371397
Total assets16,68116,52116,149
LIABILITIES
Accounts payable2,2362,1792,259
Accrued expenses124125121
Notes payable/short-term debt000
Current portion long-term debt/capital leases261261240
Other current liabilities, total686691663
Total current liabilities3,3073,2573,282
Total long term debt1,9382,1682,343
Total debt2,1992,4292,583
Deferred income tax1217--
Minority interest246296224
Other liabilities, total241199186
Total liabilities5,7445,9366,035
SHAREHOLDERS EQUITY
Common stock983983983
Additional paid-in capital1,0151,0151,015
Retained earnings (accumulated deficit)9,6089,3048,813
Treasury stock - common(757)(757)(728)
Unrealized gain (loss)884031
Other equity, total00.000.00
Total equity10,93710,58510,114
Total liabilities & shareholders' equity16,68116,52116,149
Total common shares outstanding3.333.333.35
Treasury shares - common primary issue0.890.890.86
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.